NIH-funded research R01 grant

Understanding the causes of systemic lupus erythematosus through genetic studies across different ancestries

Official title: Integrative approaches to understand systemic lupus erythematosus etiology in trans-ancestry genetic studies

Funded at Pennsylvania State Univ Hershey Med Ctr · NIH-10887632 · Data updated 2026-11-12

This study is looking into the genetic reasons behind systemic lupus erythematosus (SLE), a condition that mainly affects young women, to help find better ways to diagnose it early and understand who might be at risk.

More Lupus research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionPennsylvania State Univ Hershey Med Ctr
NIH-funded
Lab location1 site (Hershey, United States)
Project startSeptember 20, 2022
Project endJuly 31, 2027
Funding year2024
Award (this year)$706,616
NIH project number5R01AI174108-03
Project IDNIH-10887632 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include young women with a diagnosis of systemic lupus erythematosus or those at risk due to family history or genetic predisposition.

Less likely to help

Patients with autoimmune diseases other than systemic lupus erythematosus may not receive direct benefits from this research.

What this research studies

This research investigates the genetic factors contributing to systemic lupus erythematosus (SLE), an autoimmune disease that predominantly affects young women. By integrating genetic data from diverse populations, the study aims to identify causal variants associated with SLE and improve early diagnosis and risk prediction. The researchers will develop advanced statistical methods to analyze and combine data from various autoimmune diseases, enhancing the understanding of SLE's etiology. Additionally, they will create software tools to facilitate further research in this area.

Why it matters

Potential benefit: If successful, this research could lead to earlier and more accurate diagnoses of systemic lupus erythematosus, improving patient outcomes and quality of life.

How similar studies have gone: Previous research has successfully utilized similar integrative genetic approaches to uncover insights into other autoimmune diseases, suggesting a promising potential for this study.

Where this research is happening

  • Pennsylvania State Univ Hershey Med Ctr
    Hershey, United States
    Active

Researchers

  • Principal investigator: Liu, Dajiang — Pennsylvania State Univ Hershey Med Ctr
  • Study coordinator: Liu, Dajiang

Related research

Other NIH-funded projects on the same topics.

  • Immunostimulatory short non-coding RNAs and lupus

    A study in people with lupus looks at tiny RNA pieces that may spark inflammation, to understand if they drive disease activity.

    NIH research Thomas Jefferson University · Philadelphia, United States · NIH-11497703

  • Antiviral factors that limit HIV in people with SLE

    Researchers at Howard University are studying how immune factors in people with lupus may help limit HIV infection.

    NIH research Howard University · Washington, United States · NIH-11470887

  • Mechanistic clues about lupus from immune disorders

    This grant looks at why certain immune disorders in people with genetic immune problems lead to lupus-like symptoms, by studying patients and mouse models.

    NIH research Seattle Children's Hospital · Seattle, United States · NIH-11449228

  • Subjective thinking challenges in adults with lupus as they age

    This grant aims to understand how lupus-related cognitive problems affect adults, especially older adults, and tests a real-time method to track daily fluctuations in those symptoms.

    NIH research Hospital for Special Surgery · New York, UNITED STATES · NIH-11442899

  • Mitochondrial targets of antibodies in lupus (SLE)

    A Johns Hopkins-led study will identify which mitochondrial membrane proteins are targeted by autoantibodies in lupus patients to understand how these immune attacks fuel the disease.

    NIH research Johns Hopkins University · Baltimore, United States · NIH-11440181

  • Influenza, Hydroxychloroquine, and the Windows of Self-Peptide Presentation in Lupus

    A doctor-researcher is studying how flu infection and the lupus medication hydroxychloroquine change the way the immune system shows self-parts to trigger or prevent lupus flares in kids.

    NIH research Children's Hosp of Philadelphia · Philadelphia, United States · NIH-11438703

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.